{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:41:05Z","timestamp":1791222065147,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.exphem.2024.104669","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T03:32:49Z","timestamp":1730518369000},"page":"104669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Inducible pluripotent stem cell models to study bone marrow failure and MDS predisposition syndromes"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7031-2219","authenticated-orcid":false,"given":"Sushree S.","family":"Sahoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-091X","authenticated-orcid":false,"given":"Majd","family":"Khiami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin W.","family":"Wlodarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2024.104669_bib0001","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","article-title":"Pathophysiology and management of inherited bone marrow failure syndromes","volume":"24","author":"Shimamura","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2024.104669_bib0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.seminhematol.2013.03.030","article-title":"Telomere dynamics in mice and humans","volume":"50","author":"Calado","year":"2013","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2024.104669_bib0003","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2024.104669_bib0004","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10875-012-9844-3","article-title":"Critical differences in hematopoiesis and lymphoid development between humans and mice","volume":"33","author":"Parekh","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.exphem.2024.104669_bib0005","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1073\/pnas.1401598111","article-title":"Transcriptional divergence and conservation of human and mouse erythropoiesis","volume":"111","author":"Pishesha","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"10.1016\/j.exphem.2024.104669_bib0006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2184.2008.00493.x","article-title":"Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors","volume":"41","author":"Yamanaka","year":"2008","journal-title":"Cell Prolif"},{"key":"10.1016\/j.exphem.2024.104669_bib0007","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104669_bib0008","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/mt.2015.180","article-title":"Modeling human bone marrow failure syndromes using pluripotent stem cells and genome engineering","volume":"23","author":"Jung","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.exphem.2024.104669_bib0009","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2019.01.006","article-title":"Disease modeling of bone marrow failure syndromes using iPSC-derived hematopoietic stem progenitor cells","volume":"71","author":"Elbadry","year":"2019","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2024.104669_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-62703-348-0_3","article-title":"A review of the methods for human iPSC derivation","volume":"997","author":"Malik","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.exphem.2024.104669_bib0011","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrg2937","article-title":"Methods for making induced pluripotent stem cells: reprogramming \u00e0 la carte","volume":"12","author":"Gonz\u00e1lez","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2024.104669_bib0012","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/biores.2019.0046","article-title":"Induced pluripotent stem cells: reprogramming platforms and applications in cell replacement therapy","volume":"9","author":"Al Abbar","year":"2020","journal-title":"Biores Open Access"},{"key":"10.1016\/j.exphem.2024.104669_bib0013","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3686","article-title":"A guide to genome engineering with programmable nucleases","volume":"15","author":"Kim","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2024.104669_bib0014","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41467-018-04252-2","article-title":"The CRISPR tool kit for genome editing and beyond","volume":"9","author":"Adli","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104669_bib0015","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.3390\/ijms22073327","article-title":"Novel CRISPR-Cas systems: an updated review of the current achievements, applications, and future research perspectives","volume":"22","author":"Nidhi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.exphem.2024.104669_bib0016","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12033-022-00567-0","article-title":"A review on the mechanism and applications of CRISPR\/Cas9\/Cas12\/Cas13\/Cas14 proteins utilized for genome engineering","volume":"65","author":"Hillary","year":"2023","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.exphem.2024.104669_bib0017","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1093\/hmg\/ddw209","article-title":"Disease modelling using human iPSCs","volume":"25","author":"Chamberlain","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.exphem.2024.104669_bib0018","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/13497413.2018.1481583","article-title":"Disease modeling of immunological disorders using induced pluripotent stem cells","volume":"41","author":"Saito","year":"2018","journal-title":"Immunol Med"},{"key":"10.1016\/j.exphem.2024.104669_bib0019","doi-asserted-by":"crossref","DOI":"10.1242\/dev.156166","article-title":"Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond","volume":"145","author":"Liu","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.exphem.2024.104669_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","article-title":"iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders","volume":"29","author":"Okano","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104669_bib0021","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature08129","article-title":"Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells","volume":"460","author":"Raya","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104669_bib0022","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1182\/blood-2012-02-408674","article-title":"Overcoming reprogramming resistance of Fanconi anemia cells","volume":"119","author":"M\u00fcller","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0023","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/stem.1308","article-title":"Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors","volume":"31","author":"Yung","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2024.104669_bib0024","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1038\/ncomms5330","article-title":"Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2024.104669_bib0025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.15252\/emmm.201303374","article-title":"Targeted gene therapy and cell reprogramming in Fanconi anemia","volume":"6","author":"Rio","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.exphem.2024.104669_bib0026","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5966\/sctm.2013-0172","article-title":"Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors","volume":"4","author":"Suzuki","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.exphem.2024.104669_bib0027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.stemcr.2015.12.001","article-title":"Overcoming pluripotent stem cell dependence on the repair of endogenous dna damage","volume":"6","author":"Chlon","year":"2016","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.exphem.2024.104669_bib0028","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.scr.2017.02.006","article-title":"Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation","volume":"20","author":"Bharathan","year":"2017","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0029","first-page":"4679","article-title":"An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation","volume":"4","author":"Marion","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2024.104669_bib0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nature08792","article-title":"Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients","volume":"464","author":"Agarwal","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104669_bib0031","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature10084","article-title":"Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells","volume":"474","author":"Batista","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104669_bib0032","article-title":"Impaired telomere maintenance and decreased canonical WNT signaling but normal ribosome biogenesis in induced pluripotent stem cells from X-linked dyskeratosis congenita patients","volume":"10","author":"Gu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2024.104669_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101540","article-title":"Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells","volume":"40","author":"Donaires","year":"2019","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0034","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.stem.2020.03.016","article-title":"Small-molecule PAPD5 inhibitors restore telomerase activity in patient stem cells","volume":"26","author":"Nagpal","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104669_bib0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41525-022-00335-8","article-title":"A missense variant in the nuclear localization signal of DKC1 causes Hoyeraal-Hreidarsson syndrome","volume":"7","author":"Chu","year":"2022","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.exphem.2024.104669_bib0036","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jcmgh.2023.06.003","article-title":"Patient-induced pluripotent stem cell-derived hepatostellate organoids establish a basis for liver pathologies in telomeropathies","volume":"16","author":"Choi","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.exphem.2024.104669_bib0037","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1172\/JCI67146","article-title":"Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs","volume":"123","author":"Winkler","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2024.104669_bib0038","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2015528118","article-title":"Telomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis","volume":"118","author":"Garc\u00eda-Castillo","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2024.104669_bib0039","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood-2013-01-478321","article-title":"Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients","volume":"122","author":"Gar\u00e7on","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0040","doi-asserted-by":"crossref","first-page":"eaah5645","DOI":"10.1126\/scitranslmed.aah5645","article-title":"Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors","volume":"9","author":"Doulatov","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2024.104669_bib0041","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/pin.13168","article-title":"Investigation of the molecular causes underlying physical abnormalities in Diamond-Blackfan anemia patients with RPL5 haploinsufficiency","volume":"71","author":"Fukui","year":"2021","journal-title":"Pathol Int"},{"key":"10.1016\/j.exphem.2024.104669_bib0042","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/cells10040734","article-title":"Eltrombopag improves erythroid differentiation in a human induced pluripotent stem cell model of Diamond Blackfan anemia","volume":"10","author":"Qanash","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.exphem.2024.104669_bib0043","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1007\/s13577-023-00946-y","article-title":"Establishment and characterization of CSCRi006-A: an induced pluripotent stem cell line generated from a patient with Diamond-Blackfan Anemia (DBA) carrying ribosomal protein S19 (RPS19) mutation","volume":"36","author":"Rani","year":"2023","journal-title":"Hum Cell"},{"key":"10.1016\/j.exphem.2024.104669_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2024.103479","article-title":"Generation of iPSC lines and isogenic gene-corrected lines from two individuals with RPS19-mutated Diamond-Blackfan anemia syndrome","volume":"79","author":"Osuna","year":"2024","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.stem.2013.04.002","article-title":"Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction","volume":"12","author":"Tulpule","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104669_bib0046","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2024.104669_bib0047","doi-asserted-by":"crossref","first-page":"14859","DOI":"10.1038\/s41598-020-71844-8","article-title":"Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors","volume":"10","author":"Hamabata","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2024.104669_bib0048","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1073\/pnas.1217039110","article-title":"Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells","volume":"110","author":"Hiramoto","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2024.104669_bib0049","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1172\/JCI80924","article-title":"Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells","volume":"125","author":"Nayak","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2024.104669_bib0050","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1189\/jlb.5A1016-445R","article-title":"Elastase inhibitors as potential therapies for ELANE-associated neutropenia","volume":"102","author":"Makaryan","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.exphem.2024.104669_bib0051","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10875-018-0580-1","article-title":"Mosaicism of an ELANE mutation in an asymptomatic mother","volume":"39","author":"Shigemura","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.exphem.2024.104669_bib0052","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3324\/haematol.2019.221804","article-title":"CRISPR\/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients","volume":"105","author":"Nasri","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2024.104669_bib0053","article-title":"Malignant transformation involving CXXC4 mutations identified in a leukemic progression model of severe congenital neutropenia","volume":"1","author":"Olofsen","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.exphem.2024.104669_bib0054","article-title":"Generation and characterization of a human iPSC line SANi007-A from a patient with a heterozygous dominant mutation in ELANE","volume":"55","author":"Aarts","year":"2021","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0055","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/bloodadvances.2020003214","article-title":"PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations","volume":"5","author":"Olofsen","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2024.104669_bib0056","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.stem.2021.03.023","article-title":"iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia","volume":"28","author":"Dannenmann","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104669_bib0057","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/01.HS9.0000848592.96984.59","article-title":"P1434: Correction of congenital neutropenia-related genes in na\u00cfve ips cells derived from patients using viral-free Crispr\/Cas9 gene-editing system","volume":"6","author":"Krzyzanowski","year":"2022","journal-title":"HemaSphere"},{"key":"10.1016\/j.exphem.2024.104669_bib0058","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3324\/haematol.2013.083873","article-title":"Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis","volume":"99","author":"Morishima","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2024.104669_bib0059","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1182\/bloodadvances.2016003798","article-title":"Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells","volume":"1","author":"Pittermann","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2024.104669_bib0060","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood-2023-173400","article-title":"Modeling TCIRG1 neutropenia by utilizing patient derived induced pluripotent stem cells","volume":"142","author":"Makaryan","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0061","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1182\/blood-2014-01-550525","article-title":"Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects","volume":"124","author":"Connelly","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0062","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1182\/blood.2020006389","article-title":"RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells","volume":"137","author":"Estevez","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0063","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1182\/blood-2017-04-780379","article-title":"Human NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation","volume":"131","author":"Li","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0064","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/leu.2014.136","article-title":"Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD\/AML patients","volume":"28","author":"Sakurai","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2024.104669_bib0065","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/blood-2014-06-585513","article-title":"Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia","volume":"125","author":"Antony-Debr\u00e9","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0066","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.exphem.2015.05.004","article-title":"Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis","volume":"43","author":"Iizuka","year":"2015","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2024.104669_bib0067","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.stemcr.2021.04.013","article-title":"Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model","volume":"16","author":"Borst","year":"2021","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.exphem.2024.104669_bib0068","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/bloodadvances.2020002709","article-title":"Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation","volume":"5","author":"Krutein","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2024.104669_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101603","article-title":"GENYOi005-A: an induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant","volume":"41","author":"Lamolda","year":"2019","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.102002","article-title":"Generation of the human induced pluripotent stem cell line (SHAMUi001-A) carrying the heterozygous c.-128G>T mutation in the 5\u2032-UTR of the ANKRD26 gene","volume":"48","author":"Tan","year":"2020","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0071","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.2020009111","article-title":"Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5\/ALDH2 deficiency","volume":"137","author":"Mu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0072","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/bloodadvances.2018017137","article-title":"GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells","volume":"2","author":"Jung","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2024.104669_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102445","article-title":"Generation of two heterozygous GATA2 CRISPR\/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency","volume":"55","author":"Casta\u00f1o","year":"2021","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102417","article-title":"Generation of human induced pluripotent stem cell lines from 2 patients with MIRAGE syndrome","volume":"54","author":"Fischer","year":"2021","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2022.102906","article-title":"Generation of heterozygous SAMD9 CRISPR\/Cas9-edited iPSC line (ESi086-A-3), carrying p.I1567M mutation","volume":"64","author":"Pera","year":"2022","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.exphem.2024.104669_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2024.103532","article-title":"Generation of CRISPR\/Cas9-edited human iPSC lines carrying homozygous and heterozygous SAMD9 p.I983S mutations","volume":"81","author":"Khiami","year":"2024","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0077","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-017-0141-1","article-title":"iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors","volume":"9","author":"Melguizo-Sanchis","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.exphem.2024.104669_bib0078","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/bloodadvances.2017013342","article-title":"Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack","volume":"2","author":"Espinoza","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2024.104669_bib0079","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.3324\/haematol.2018.210856","article-title":"Escape hematopoiesis by HLA-B5401-lacking hematopoietic stem progenitor cells in men with acquired aplastic anemia","volume":"104","author":"Elbadry","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2024.104669_bib0080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41419-022-04850-5","article-title":"Defective hematopoietic differentiation of immune aplastic anemia patient-derived iPSCs","volume":"13","author":"Tellechea","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.exphem.2024.104669_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2023.103128","article-title":"Derivation of breast cancer patient derived human induced pluripotent stem cell line (YBLi006-A) with FANC-BRCA gene mutations: a resource for precision & personalized medicine","volume":"70","author":"Chitrangi","year":"2023","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0082","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2013-09-427740","article-title":"Why does the bone marrow fail in Fanconi anemia?","volume":"123","author":"Garaycoechea","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0083","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature11863","article-title":"Fanconi anaemia and the repair of Watson and Crick DNA crosslinks","volume":"493","author":"Kottemann","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2024.104669_bib0084","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mrfmmm.2009.03.015","article-title":"Mouse models of Fanconi anemia","volume":"668","author":"Parmar","year":"2009","journal-title":"Mutat Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0085","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood-2003-01-0114","article-title":"TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro","volume":"102","author":"Dufour","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0086","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMra0903373","article-title":"Telomere diseases","volume":"361","author":"Calado","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104669_bib0087","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41576-022-00527-z","article-title":"Genetics of human telomere biology disorders","volume":"24","author":"Revy","year":"2023","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2024.104669_bib0088","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/cr.2011.120","article-title":"Telomere dynamics in dyskeratosis congenita: the long and the short of iPS","volume":"21","author":"Agarwal","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0089","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/genes13081395","article-title":"Patient-derived iPSCs reveal evidence of telomere instability and DNA repair deficiency in coats plus syndrome","volume":"13","author":"Oudrhiri","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.exphem.2024.104669_bib0090","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/ng.3423","article-title":"Poly(A)-specific ribonuclease (PARN) mediates 3\u2032-end maturation of the telomerase RNA component","volume":"47","author":"Moon","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2024.104669_bib0091","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood.2021011980","article-title":"Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue","volume":"139","author":"Sharma","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0092","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2010-02-251090","article-title":"How I treat Diamond-Blackfan anemia","volume":"116","author":"Vlachos","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0093","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S2352-3026(24)00063-2","article-title":"Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement","volume":"11","author":"Wlodarski","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.exphem.2024.104669_bib0094","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjh.12058","article-title":"Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia","volume":"159","author":"Horos","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104669_bib0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.seminhematol.2006.04.006","article-title":"Shwachman-Diamond syndrome","volume":"43","author":"Shimamura","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2024.104669_bib0096","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1182\/blood-2012-04-420166","article-title":"Impaired ribosomal subunit association in Shwachman-Diamond syndrome","volume":"120","author":"Burwick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0097","doi-asserted-by":"crossref","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.exphem.2024.104669_bib0098","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2024.104669_bib0099","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ejhg.2008.89","article-title":"Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions","volume":"16","author":"B\u00e9ri-Dexheimer","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.exphem.2024.104669_bib0100","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1182\/blood-2010-12-325555","article-title":"Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder\/acute myelogenous leukemia","volume":"118","author":"Bluteau","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0101","first-page":"547","article-title":"[Aldehyde degradation deficiency (ADD) syndrome: discovery of a novel fanconi anemia-like inherited BMF syndrome due to combined ADH5\/ALDH2 deficiency]","volume":"62","author":"Mu","year":"2021","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.exphem.2024.104669_bib0102","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104669_bib0103","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjh.18330","article-title":"GATA2 deficiency and MDS\/AML: Experimental strategies for disease modelling and future therapeutic prospects","volume":"199","author":"Kotmayer","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104669_bib0104","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2024.104669_bib0105","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI91913","article-title":"Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans","volume":"127","author":"Buonocore","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2024.104669_bib0106","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","article-title":"Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes","volume":"27","author":"Sahoo","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2024.104669_bib0107","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104669_bib0108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10577-019-09623-z","article-title":"Structural variant identification and characterization","volume":"28","author":"Balachandran","year":"2020","journal-title":"Chromosome Res"},{"key":"10.1016\/j.exphem.2024.104669_bib0109","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41596-020-0309-5","article-title":"CRISPR off-target detection with DISCOVER-seq","volume":"15","author":"Wienert","year":"2020","journal-title":"Nat Protoc"},{"key":"10.1016\/j.exphem.2024.104669_bib0110","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1038\/s41596-021-00626-x","article-title":"Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq","volume":"16","author":"Malinin","year":"2021","journal-title":"Nat Protoc"},{"key":"10.1016\/j.exphem.2024.104669_bib0111","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.stem.2023.11.002","article-title":"Generation of transgene-free hematopoietic stem cells from human induced pluripotent stem cells","volume":"30","author":"Piau","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2024.104669_bib0112","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-024-02360-7","article-title":"Long-term engrafting multilineage hematopoietic cells differentiated from human induced pluripotent stem cells","author":"Ng","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2024.104669_bib0113","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41592-024-02172-2","article-title":"Generation of complex bone marrow organoids from human induced pluripotent stem cells","volume":"21","author":"Frenz-Wiessner","year":"2024","journal-title":"Nat Methods"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T10:08:26Z","timestamp":1740823706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X24005344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":113,"alternative-id":["S0301472X24005344"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104669","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inducible pluripotent stem cell models to study bone marrow failure and MDS predisposition syndromes","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104669"}}